COVID-19 e o impacto no sistema cardiovascular
##plugins.themes.bootstrap3.article.sidebar##
Publicado
Oct 31, 2024
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Analisar e correlacionar o impacto cardiovascular da COVID-19, em pacientes com comorbidades e os fatores de risco associados aos danos gerados pela infecção, assim como prognostico e sua relação com a mortalidade. Métodos: Trata-se de um de uma revisão integrativa da literatclinico comigos publicados entre 2020 e 2023, incluindo estudos observacionais e ensaio clinico com texto completo disponível. A busca foi realizada nas bases de dados: National Libery of Medicine (Pubmed) e Portal Regional da BVS. Como descritores na busca pelos artigos, foram utilizados: ´´Covid-19´´, impact ´´, ´´cardiovascular system´´, associado ao operador booleriano ´´AND´´. Resultados: Foram selecionados 11 artigos na base de dados Pubmed e 8 artigos no Portal regional da BVS, sendo que 6 artigos foram retirados deste estudo por estarem duplicados entre as plataformas, tendo como resultado 19 artigos. Considerações finais: Em conclusão, é importante que profissionais de saúde saibam identificar e manejar as alterações cardíacas durante o curso da COVID-19, devido à seu impacto no sistema cardiovascular e na mortalidade.
##plugins.themes.bootstrap3.article.details##
Como Citar
NascimentoN. S. do, OliveiraL. M. de M., & SiqueiraE. C. de. (2024). COVID-19 e o impacto no sistema cardiovascular. Revista Eletrônica Acervo Médico, 24, e18000. https://doi.org/10.25248/reamed.e18000.2024
Seção
Revisão Bibliográfica
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
1. ÁGUILA-GORDO D. et al. Enfermedad cardiovascular tras infección por SARS-CoV-2 en pacientes ancianos. Resultados del seguimiento anual de una cohorte de supervivientes. Revista Española de Geriatría y Gerontología, 2021; 57(2): 100–104.
2. ALEKSOVA A, et al. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. International Journal of Molecular Sciences, 2021; 22(9): 4526-4540.
3. ANALIS A, et al. COVID-19 infection and cardiac arrhythmias. Trends in Cardiovascular Medicine, 2020; 30(8): 451-460.
4. ARABADJIAN M, et al. COVID-19 in Adults With Hypertrophic Cardiomyopathy. Directory of Open Acces Journals, 2021; 8.
5. AZEVEDO R, et al. COVID-19 and the cardiovascular system: a comprehensive review. Journal of Huma Hypertension, 2020; 35(1): 4-11.
6. BOURGONJE AR, et al. Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19). The Journal of Pathology, 2020; 251(3): 228-248.
7. CARO-CODÓN J, et al. Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients. Revista Portuguesa de Cardiologia. 2022; 41(10): 823-830.
8. CHEN Q, et l. Cardiovascular manifestations in severe and critical patients with COVID ‐19. Clinical Cardiology. 2020; 43(7): 796-802.
9. CONNORS JM e LEVY JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020; 135(23): 2033-2040.
10. COSTA I, et al. Cardiovascular imaging and interventional procedures in patients with novel Coronavirus in infection. Arquivos brasileiros de cardiologia. 2020; 115(1): 111-116.
11. DA SILVA SJR. et al. Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infectious Diseases. 2022; 8(9): 1758-1814.
12. DEUEL JW. et al. Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss Armed Forces: a longitudinal, cohort study (LoCoMo). The Lancet Infectious Diseases. 2022; 22(12): 1694-1702.
13. DIAZ-AROCUPITA C, et al. Pericarditis in patientes whit COVID-19: a sistematic review. Journal of Cardiovascular Medicine. 2021; 22(9): 693-700.
14. GARCIA S, et al. Initial Findings from the North America COVID-19 Myocardical infarction Registry. Journal of American College of Cardiology. 2021; 77: 1994-2003.
15. HUANG N, et al. Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in Eats-Asian patients with COVID-19. 2023; 18(1): 0280280.
16. KHAWAJA S, et al. COVID-19 And Its impacto n the cardiovascular system. Open Heart. 2021; 8(1): 001472.
17. KINI A, et al. Types of myocardial injury and mid – term outcomes in patients whit COVID-19. European Heart Journal-Quality of care clinical outcomes. 2021; 7(5): 438-446.
18. KUNAL S, et al. Cardiovascular complications and its impact on outcomes in COVID-19. Indian Heart Journal. 2020; 72(6): 593-598.
19. LAÍREZ O, et al. Cardiac imagingphenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study. International Journalof Cardiovascular Imaging. 2021; 37(2): 449-457.
20. MAGALHÃES BK, et al. The impact of chronic cardiovascular disease on COVID-19 clinical course. Journal of clinical and translational research. 2022; 8(4): 308-322.
21. MALATY M, et al. Incidence and treatmen of arrhythmias secundary to coronavirua infection in humans: A systematic review. European Journal of Clinical Investigation. 2020; 51(2): 13428.
22. MANCIA G, et al. Renin-Angiotensin-Aldosterone System Blockers and the risk of COVID-19. New England Journal of Medicine. 2020; 385(25): 2431-2440.
23. MARFELLA R, et al. SARS-COV-2 colonizes coronary thrombus and impairs heart micro circulation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction. CriticalCare. 2021; 25(1): 217-229.
24. NAGY É, et al. The Impact of Comorbidities and Obesity on the Severity and Outcome of COVID-19 in Hospitalized Patients—A Retrospective Study in a Hungarian Hospital. International Journal of Environmental Research and Public Health. 2023; 20(2): 1372-1387.
25. OLIVEIRA GMM, et al. Estatística Cardiovascular – Brasil 2021. Arq. Bras. Cardiol. 2022; 118(1): 115-373.
26. PARK B, et al. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City. Journal of Korean Medical Science. 2021; 6(2): 15.
27. RUSSO V, et al. Clinical characteristics and prognosis of hospitalized COVID‐19 patients with incident sustained tachyarrhythmias: A multicenter observational study. European Journal of Clinical Investigation. 2020; 50(12): 13387.
28. SAEED S, et al. The cardiovascular complications in COVID-19: Focus on acute cardiac injury. Pakistan Journal of Medical Sciences. 2021; 37(3): 908-912.
29. SANZ A, et al. New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis. Cardiology Journal2020. 2021; 28(1): 34-40.
30. SATO K, et al. Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study. BMC Cardiovascular Disorders. 2022; 22(1): 132-144.
31. SHARMA, A, et al. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2020; 13(2): 202.
32. SHEEHAN M, et al. Echocardiography in suspected corona vírus infection: indications, limitations and impact on clinical management. Open Heart. 2021; 8(2): 001702.
33. SOUZA, ASR. et al. Aspectos gerais da pandemia de COVID-19. Revista Brasileira de Saúde Materno Infantil. 2021; 21(1): 29-45.
34. VILLALBA G, et al. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19. Cardiology Journal. 2021; 28(3): 960-368.
35. YE Z, et al. COVID-19 and the cardiovascular system: a comprehensive review. Journal of Huma Hypertension. 2020; 30(8): 4381-1389.
2. ALEKSOVA A, et al. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. International Journal of Molecular Sciences, 2021; 22(9): 4526-4540.
3. ANALIS A, et al. COVID-19 infection and cardiac arrhythmias. Trends in Cardiovascular Medicine, 2020; 30(8): 451-460.
4. ARABADJIAN M, et al. COVID-19 in Adults With Hypertrophic Cardiomyopathy. Directory of Open Acces Journals, 2021; 8.
5. AZEVEDO R, et al. COVID-19 and the cardiovascular system: a comprehensive review. Journal of Huma Hypertension, 2020; 35(1): 4-11.
6. BOURGONJE AR, et al. Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19). The Journal of Pathology, 2020; 251(3): 228-248.
7. CARO-CODÓN J, et al. Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients. Revista Portuguesa de Cardiologia. 2022; 41(10): 823-830.
8. CHEN Q, et l. Cardiovascular manifestations in severe and critical patients with COVID ‐19. Clinical Cardiology. 2020; 43(7): 796-802.
9. CONNORS JM e LEVY JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020; 135(23): 2033-2040.
10. COSTA I, et al. Cardiovascular imaging and interventional procedures in patients with novel Coronavirus in infection. Arquivos brasileiros de cardiologia. 2020; 115(1): 111-116.
11. DA SILVA SJR. et al. Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infectious Diseases. 2022; 8(9): 1758-1814.
12. DEUEL JW. et al. Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss Armed Forces: a longitudinal, cohort study (LoCoMo). The Lancet Infectious Diseases. 2022; 22(12): 1694-1702.
13. DIAZ-AROCUPITA C, et al. Pericarditis in patientes whit COVID-19: a sistematic review. Journal of Cardiovascular Medicine. 2021; 22(9): 693-700.
14. GARCIA S, et al. Initial Findings from the North America COVID-19 Myocardical infarction Registry. Journal of American College of Cardiology. 2021; 77: 1994-2003.
15. HUANG N, et al. Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in Eats-Asian patients with COVID-19. 2023; 18(1): 0280280.
16. KHAWAJA S, et al. COVID-19 And Its impacto n the cardiovascular system. Open Heart. 2021; 8(1): 001472.
17. KINI A, et al. Types of myocardial injury and mid – term outcomes in patients whit COVID-19. European Heart Journal-Quality of care clinical outcomes. 2021; 7(5): 438-446.
18. KUNAL S, et al. Cardiovascular complications and its impact on outcomes in COVID-19. Indian Heart Journal. 2020; 72(6): 593-598.
19. LAÍREZ O, et al. Cardiac imagingphenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study. International Journalof Cardiovascular Imaging. 2021; 37(2): 449-457.
20. MAGALHÃES BK, et al. The impact of chronic cardiovascular disease on COVID-19 clinical course. Journal of clinical and translational research. 2022; 8(4): 308-322.
21. MALATY M, et al. Incidence and treatmen of arrhythmias secundary to coronavirua infection in humans: A systematic review. European Journal of Clinical Investigation. 2020; 51(2): 13428.
22. MANCIA G, et al. Renin-Angiotensin-Aldosterone System Blockers and the risk of COVID-19. New England Journal of Medicine. 2020; 385(25): 2431-2440.
23. MARFELLA R, et al. SARS-COV-2 colonizes coronary thrombus and impairs heart micro circulation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction. CriticalCare. 2021; 25(1): 217-229.
24. NAGY É, et al. The Impact of Comorbidities and Obesity on the Severity and Outcome of COVID-19 in Hospitalized Patients—A Retrospective Study in a Hungarian Hospital. International Journal of Environmental Research and Public Health. 2023; 20(2): 1372-1387.
25. OLIVEIRA GMM, et al. Estatística Cardiovascular – Brasil 2021. Arq. Bras. Cardiol. 2022; 118(1): 115-373.
26. PARK B, et al. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City. Journal of Korean Medical Science. 2021; 6(2): 15.
27. RUSSO V, et al. Clinical characteristics and prognosis of hospitalized COVID‐19 patients with incident sustained tachyarrhythmias: A multicenter observational study. European Journal of Clinical Investigation. 2020; 50(12): 13387.
28. SAEED S, et al. The cardiovascular complications in COVID-19: Focus on acute cardiac injury. Pakistan Journal of Medical Sciences. 2021; 37(3): 908-912.
29. SANZ A, et al. New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis. Cardiology Journal2020. 2021; 28(1): 34-40.
30. SATO K, et al. Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study. BMC Cardiovascular Disorders. 2022; 22(1): 132-144.
31. SHARMA, A, et al. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2020; 13(2): 202.
32. SHEEHAN M, et al. Echocardiography in suspected corona vírus infection: indications, limitations and impact on clinical management. Open Heart. 2021; 8(2): 001702.
33. SOUZA, ASR. et al. Aspectos gerais da pandemia de COVID-19. Revista Brasileira de Saúde Materno Infantil. 2021; 21(1): 29-45.
34. VILLALBA G, et al. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19. Cardiology Journal. 2021; 28(3): 960-368.
35. YE Z, et al. COVID-19 and the cardiovascular system: a comprehensive review. Journal of Huma Hypertension. 2020; 30(8): 4381-1389.